Biology + AI that enables
human potential

Legacy Venture Capital leverages community to find, fund, and support the best life sciences startups from Day 1.

Pre-Seed

& Seed Stage

12–14%

Market CAGR

The Opportunity

There has never been a bigger market opportunity for emerging life science companies.

Launching a life sciences company is hard. Most founders navigate it alone. Legacy is a venture firm that leverages community to invest in pre-seed and seed life sciences startups that enhance human potential.

Read Our Thesis →

◇

Performance

△

Vitality

○

Longevity

◈

Human Potential

Our Differentiator

Our deep bonds create a new community together that didn't exist before.

Scientists & Clinicians

Faculty networks across Harvard, MIT, Stanford, NIH, and 30+ top institutions powering proprietary deal flow.

Celebrity & Media

1MM+ followers, partnerships with 600+ Fortune 1000 clients, and coverage across Forbes, WSJ, and Bloomberg.

Co-Investors

Deep relationships with SoftBank, a16z, Y Combinator, and leading life sciences VC firms for follow-on support.

Now Accepting Nominations

The Legacy Prize

$10K unrestricted grant honoring scientists whose breakthrough research is poised to transform human health.

Learn More →

Biology + AI that enableshuman potential